Your browser doesn't support javascript.
loading
Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection
Rebecca L Smith; Laura L Gibson; Pamela P Martinez; Ruian Ke; Agha Mirza; Madison Conte; Nicholas Gallagher; Abigail Conte; Leyi Wang; Rick Fredrickson; Darci C Edmonson; Melinda E Baughman; Karen K Chiu; Hannah Choi; Tor W Jensen; Kevin R Scardina; Shannon Bradley; Stacy L Gloss; Crystal Reinhart; Jagadeesh Yedetore; Alyssa N Owens; John Broach; Bruce Barton; Peter Lazar; Darcy Henness; Todd Young; Alastair Dunnett; Matthew L Robinson; Heba H Mostafa; Andrew Pekosz; Yukari C Manabe; William J Heetderks; David D McManus; Christopher B Brooke.
Affiliation
  • Rebecca L Smith; University of Illinois at Urbana-Champaign
  • Laura L Gibson; University of Massachusetts Medical School
  • Pamela P Martinez; University of Illinois at Urbana-Champaign
  • Ruian Ke; Los Alamos National Laboratory
  • Agha Mirza; Johns Hopkins University
  • Madison Conte; Johns Hopkins University
  • Nicholas Gallagher; Johns Hopkins University
  • Abigail Conte; Johns Hopkins University
  • Leyi Wang; University of Illinois at Urbana-Champaign
  • Rick Fredrickson; University of Illinois at Urbana-Champaign
  • Darci C Edmonson; University of Illinois at Urbana-Champaign
  • Melinda E Baughman; University of Illinois at Urbana-Champaign
  • Karen K Chiu; University of Illinois at Urbana-Champaign
  • Hannah Choi; University of Illinois at Urbana-Champaign
  • Tor W Jensen; University of Illinois at Urbana-Champaign
  • Kevin R Scardina; University of Illinois at Urbana-Champaign
  • Shannon Bradley; University of Illinois at Urbana-Champaign
  • Stacy L Gloss; University of Illinois at Urbana-Champaign
  • Crystal Reinhart; University of Illinois at Urbana-Champaign
  • Jagadeesh Yedetore; University of Illinois at Urbana-Champaign
  • Alyssa N Owens; University of Massachusetts Medical School
  • John Broach; UMass Memorial Medical Center
  • Bruce Barton; University of Massachusetts Medical School
  • Peter Lazar; University of Massachusetts Medical School
  • Darcy Henness; Carle Foundation Hospital
  • Todd Young; Carle Foundation Hospital
  • Alastair Dunnett; Carle Foundation Hospital
  • Matthew L Robinson; Johns Hopkins School of Medicine
  • Heba H Mostafa; Johns Hopkins University School of Medicine
  • Andrew Pekosz; Johns Hopkins Bloomberg School of Public Health
  • Yukari C Manabe; Johns Hopkins University School of Medicine
  • William J Heetderks; National Institute for Biomedical Imaging and Bioengineering
  • David D McManus; University of Massachusetts Medical School
  • Christopher B Brooke; University of Illinois at Urbana-Champaign
Preprint in English | medRxiv | ID: ppmedrxiv-21253964
Journal article
A scientific journal published article is available and is probably based on this preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See journal article
ABSTRACT
What is already known about this topic?Diagnostic tests and sample types for SARS-CoV-2 vary in sensitivity across the infection period. What is added by this report?We show that both RTqPCR (from nasal swab and saliva) and the Quidel SARS Sofia FIA rapid antigen tests peak in sensitivity during the period in which live virus can be detected in nasal swabs, but that the sensitivity of RTqPCR tests rises more rapidly in the pre-infectious period. We also use empirical data to estimate the sensitivities of RTqPCR and antigen tests as a function of testing frequency. What are the implications for public health practice?RTqPCR tests will be more effective than rapid antigen tests at identifying infected individuals prior to or early during the infectious period and thus for minimizing forward transmission (provided results reporting is timely). All modalities, including rapid antigen tests, showed >94% sensitivity to detect infection if used at least twice per week. Regular surveillance/screening using rapid antigen tests 2-3 times per week can be an effective strategy to achieve high sensitivity (>95%) for identifying infected individuals.
License
cc_no
Full text: Available Collection: Preprints Database: medRxiv Type of study: Diagnostic study / Prognostic study Language: English Year: 2021 Document type: Preprint
Full text: Available Collection: Preprints Database: medRxiv Type of study: Diagnostic study / Prognostic study Language: English Year: 2021 Document type: Preprint
...